NAV | $30.06 | Daily Change | -$0.04 | -0.13% |
Market Price | $30.08 | Daily Change | -$0.08 | -0.27% |
Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1
With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.
The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.
1WHO, Oct 2022
Inception Date | 05/09/16 |
Total Expense Ratio | 0.50% |
Net Assets | $58.61 million |
NAV | $30.06 |
Fact Sheet | View the document |
The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.
The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
Ticker | AGNG |
Bloomberg Index Ticker | ILNGRNT |
CUSIP | 37954Y772 |
ISIN | US37954Y7720 |
Primary Exchange | Nasdaq |
Shares Outstanding | 1,950,000 |
Number of Holdings | 85 |
30-Day Median Bid-Ask Spread | 0.33% |
30-Day SEC Yield | 0.97% |
Distribution Frequency | Semi-Annually |
NAV | $30.06 | Daily Change | -$0.04 | -0.13% |
Market Price | $30.08 | Daily Change | -$0.08 | -0.27% |
As of recent (03/31/24)
As of recent (03/31/24)
|
Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | 12.59% | 13.50% | 12.98% |
3 Years | 3.44% | 3.51% | 3.67% |
5 Years | 7.66% | 7.65% | 7.90% |
Since Inception | 9.77% | 10.13% | 10.05% |
1 Year | 10.08% | 10.62% | 10.45% |
3 Years | 1.25% | 1.33% | 1.39% |
5 Years | 8.80% | 8.68% | 9.05% |
Since Inception | 9.41% | 9.72% | 9.69% |
Year-to-Date | 5.09% | 5.87% | 5.14% |
1 Month | 2.64% | 2.10% | 2.74% |
3 Months | 5.09% | 5.87% | 5.14% |
Since Inception | 108.76% | 114.23% | 113.11% |
Year-to-Date | 3.96% | 4.47% | 4.06% |
1 Month | 3.24% | 3.48% | 3.30% |
3 Months | 1.54% | 0.75% | 1.68% |
Since Inception | 106.53% | 111.39% | 110.91% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
3.47 | LLY | ELI LILLY & CO | 2516152 | 905.38 | 2,247 | 2,034,388.86 |
3.37 | NOVOB DC | NOVO NORDISK A/S-B | BP6KMJ1 | 144.52 | 13,681 | 1,977,179.96 |
3.37 | AMGN | AMGEN INC | 2023607 | 312.45 | 6,322 | 1,975,308.90 |
3.36 | WELL | WELLTOWER INC | BYVYHH4 | 104.25 | 18,888 | 1,969,074.00 |
3.33 | REGN | REGENERON PHARMACEUTICALS | 2730190 | 1,051.03 | 1,855 | 1,949,660.65 |
3.27 | AZN | ASTRAZENECA PLC-SPONS ADR | 2989044 | 77.99 | 24,577 | 1,916,760.23 |
3.26 | BSX | BOSTON SCIENTIFIC CORP | 2113434 | 77.01 | 24,795 | 1,909,462.95 |
3.17 | ALC SW | ALCON INC | BJT1GR5 | 89.27 | 20,789 | 1,855,879.79 |
3.03 | 4519 JP | CHUGAI PHARMA CO | 6196408 | 35.53 | 50,005 | 1,776,877.91 |
2.98 | ABBV | ABBVIE INC | B92SR70 | 171.52 | 10,188 | 1,747,445.76 |
2.94 | EW | EDWARDS LIFESCIENCES CORP | 2567116 | 92.37 | 18,670 | 1,724,547.90 |
2.86 | SYK | STRYKER CORP | 2853688 | 340.25 | 4,928 | 1,676,752.00 |
2.86 | JNJ | JOHNSON & JOHNSON | 2475833 | 146.16 | 11,470 | 1,676,455.20 |
2.86 | RO SW | ROCHE HOLDING AG-BR | 7108918 | 304.70 | 5,495 | 1,674,305.59 |
2.79 | MDT | MEDTRONIC PLC | BTN1Y11 | 78.71 | 20,768 | 1,634,649.28 |
2.55 | UCB BB | UCB SA | 5596991 | 148.65 | 10,047 | 1,493,509.35 |
2.46 | BMY | BRISTOL-MYERS SQUIBB CO | 2126335 | 41.53 | 34,735 | 1,442,544.55 |
2.42 | 068270 KS | CELLTRION INC | B0C5YV1 | 126.63 | 11,194 | 1,417,445.84 |
2.36 | DXCM | DEXCOM INC | B0796X4 | 113.38 | 12,219 | 1,385,390.22 |
2.17 | 4543 JP | TERUMO CORP | 6885074 | 16.49 | 76,985 | 1,269,682.99 |
1.96 | ZBH | ZIMMER BIOMET HO | 2783815 | 108.53 | 10,565 | 1,146,619.45 |
1.80 | VTR | VENTAS INC | 2927925 | 50.81 | 20,728 | 1,053,189.68 |
1.73 | STMN SW | STRAUMANN HOLDING AG-REG | BQ7ZV06 | 123.86 | 8,204 | 1,016,142.00 |
1.62 | SOON SW | SONOVA HOLDING AG-REG | 7156036 | 308.92 | 3,067 | 947,472.96 |
1.58 | 4503 JP | ASTELLAS PHARMA INC | 6985383 | 9.88 | 93,667 | 925,839.43 |
1.46 | GMAB DC | GENMAB A/S | 4595739 | 250.78 | 3,411 | 855,421.66 |
1.38 | SDZ SW | SANDOZ GROUP AG | BLPLD38 | 36.21 | 22,263 | 806,185.20 |
1.32 | UTHR | UNITED THERAPEUTICS CORP | 2430412 | 318.55 | 2,422 | 771,528.10 |
1.28 | COH AU | COCHLEAR LTD | 6211798 | 221.83 | 3,373 | 748,221.48 |
1.24 | PODD | INSULET CORP | B1XGNW4 | 201.80 | 3,603 | 727,085.40 |
1.20 | NBIX | NEUROCRINE BIOSC | 2623911 | 137.67 | 5,119 | 704,732.73 |
1.20 | BGNE | BEIGENE LTD-ADR | BYYWPW6 | 142.67 | 4,921 | 702,079.07 |
1.20 | INCY | INCYTE CORP | 2471950 | 60.62 | 11,551 | 700,221.62 |
1.09 | 3692 HK | HANSOH PHARMACEU | BJYKB72 | 2.09 | 306,243 | 640,147.27 |
1.07 | DVA | DAVITA INC | 2898087 | 138.57 | 4,532 | 627,999.24 |
0.99 | FME GR | FRESENIUS MEDICAL CARE AG | 5129074 | 38.33 | 15,187 | 582,055.75 |
0.96 | SN/ LN | SMITH & NEPHEW PLC | 0922320 | 12.40 | 45,262 | 561,054.73 |
0.87 | TFX | TELEFLEX INC | 2881407 | 210.33 | 2,417 | 508,367.61 |
0.86 | DEMANT DC | DEMANT A/S | BZ01RF1 | 43.32 | 11,594 | 502,203.39 |
0.74 | OHI | OMEGA HEALTHCARE | 2043274 | 34.25 | 12,670 | 433,947.50 |
0.71 | AMP IM | AMPLIFON SPA | B14NJ71 | 35.63 | 11,720 | 417,526.18 |
0.68 | EXAS | EXACT SCIENCES CORP | 2719951 | 42.25 | 9,377 | 396,178.25 |
0.62 | ENSG | ENSIGN GROUP INC/THE | B1YWPP8 | 123.69 | 2,927 | 362,040.63 |
0.60 | EXEL | EXELIXIS INC | 2576941 | 22.47 | 15,663 | 351,947.61 |
0.59 | HALO | HALOZYME THERAPEUTICS INC | 2975098 | 52.36 | 6,569 | 343,952.84 |
0.58 | BPMC | BLUEPRINT MEDICINES CORP | BWY52P3 | 107.78 | 3,165 | 341,123.70 |
0.54 | YPSN SW | YPSOMED HOLDING AG-REG | B02SWN8 | 447.36 | 701 | 313,601.16 |
0.52 | GKOS | GLAUKOS CORP | BYMWL19 | 118.35 | 2,556 | 302,502.60 |
0.44 | MMSI | MERIT MEDICAL SYSTEMS INC | 2580555 | 85.95 | 2,996 | 257,506.20 |
0.41 | AGIO | AGIOS PHARMACEUTICALS INC | BCBVTX1 | 43.12 | 5,588 | 240,954.56 |
0.41 | SILK | SILK ROAD MEDICAL INC | BGHVXJ7 | 27.04 | 8,846 | 239,195.84 |
0.37 | GN DC | GN STORE NORD A/S | 4501093 | 27.90 | 7,811 | 217,888.98 |
0.36 | AGL | AGILON HEALTH INC | BLR4TK4 | 6.54 | 32,084 | 209,829.36 |
0.35 | NVCR | NOVOCURE LTD | BYSS4X4 | 17.13 | 12,110 | 207,444.30 |
0.35 | MNKD | MANNKIND CORP | BF081J4 | 5.22 | 39,265 | 204,963.30 |
0.35 | DNLI | DENALI THERAPEUTICS INC | BD2B4V0 | 23.22 | 8,802 | 204,382.44 |
0.35 | NHC | NATIONAL HEALTHCARE CORP | 2139731 | 108.40 | 1,880 | 203,792.00 |
0.34 | ITGR | INTEGER HOLDINGS CORP | BD06LM7 | 115.79 | 1,730 | 200,316.70 |
0.34 | PHM SM | PHARMA MAR SA | BMW2GT8 | 34.10 | 5,776 | 196,980.14 |
0.33 | EMBC | EMBECTA CORP | BMXWYR1 | 12.50 | 15,536 | 194,200.00 |
0.33 | NHI | NATL HEALTH INVESTORS INC | 2626125 | 67.73 | 2,864 | 193,978.72 |
0.32 | SBRA | SABRA HEALTH CAR | B5NLBP6 | 15.40 | 12,234 | 188,403.60 |
0.31 | LTC | LTC PROPERTIES INC | 2498788 | 34.50 | 5,316 | 183,402.00 |
0.31 | SIA CN | SIENNA SENIOR LIVING INC | BWTYXH4 | 10.41 | 17,387 | 181,068.26 |
0.30 | 9229 JP | SUNWELS CO LTD | BNTYNB5 | 16.37 | 10,734 | 175,763.74 |
0.30 | CSH-U CN | CHARTWELL RETIRE | B8S8C94 | 9.39 | 18,655 | 175,186.72 |
0.30 | BKD | BROOKDALE SR | B0PZN33 | 6.83 | 25,360 | 173,208.80 |
0.29 | LIVN | LIVANOVA PLC | BYMT0J1 | 54.82 | 3,119 | 170,983.58 |
0.29 | AMED | AMEDISYS INC | 2024332 | 91.80 | 1,829 | 167,902.20 |
0.28 | AED BB | AEDIFICA | B1G5XP1 | 60.71 | 2,745 | 166,662.27 |
0.28 | 2186 HK | LUYE PHARMA GROUP LTD | BNQ4GF3 | 0.35 | 475,024 | 164,275.53 |
0.27 | 8086 JP | NIPRO CORP | 6641599 | 7.84 | 20,454 | 160,404.83 |
0.27 | TBPH | THERAVANCE BIOPHARMA INC | BMNDK09 | 8.48 | 18,861 | 159,941.28 |
0.27 | ACAD | ACADIA PHARMACEU | 2713317 | 16.25 | 9,825 | 159,656.25 |
0.27 | 145720 KS | DENTIUM CO LTD | BF07GJ6 | 85.94 | 1,810 | 155,556.12 |
0.25 | 853 HK | MICROPORT SCIENTIFIC CORP | B676TW7 | 0.68 | 220,702 | 148,973.99 |
0.25 | EKTAB SS | ELEKTA AB-B SHS | B0M42T2 | 6.25 | 23,060 | 144,149.50 |
0.23 | RYM NZ | RYMAN HEALTHCARE LTD | 6161525 | 2.17 | 62,560 | 135,710.78 |
0.23 | 1789 HK | AK MEDICAL HOLDINGS LTD | BFD6SZ0 | 0.55 | 245,689 | 135,630.25 |
0.23 | 1302 HK | LIFETECH SCIENTIFIC CORP | BV9FKS0 | 0.18 | 750,292 | 133,579.15 |
0.22 | ATEC | ALPHATEC HOLDINGS INC | BD60BG7 | 10.45 | 12,203 | 127,521.35 |
0.21 | ALEC | ALECTOR INC | BJ4LDC4 | 4.54 | 26,956 | 122,380.24 |
0.19 | CASH | 1.00 | 112,394 | 112,393.64 | ||
0.10 | 2500 HK | VENUS MEDTECH -H | BL6V047 | 0.54 | 102,940 | 55,574.47 |
0.07 | OTHER PAYABLE & RECEIVABLES | 1.00 | 39,970 | 39,969.92 | ||
0.01 | KOREAN WON | 0.00 | 9,883,820 | 7,180.40 | ||
0.01 | CANADIAN DOLLAR | 0.73 | 4,297 | 3,140.16 | ||
0.00 | AMPLIFON SPA - RTS | BS4BKD7 | 0.00 | 12,182 | 0.28 | |
0.00 | CURRENCY CONTRACT - USD | 0.00 | -26,058 | -0.98 | ||
0.00 | JAPANESE YEN | 0.01 | -301,614 | -1,875.01 | ||
0.00 | EURO | 1.07 | -2,383 | -2,553.76 | ||
CURRENCY CONTRACT - USD | 0.00 | 3,337 | ||||
RADIUS HEALTH INC - CVR | 2KFF9T0 | 0.00 | 19,104 |
Sector | Weight (%) | |
---|---|---|
Health Care | 92.9 | |
Real Estate | 7.1 |
Industry | Weight (%) | |
---|---|---|
Medical Specialties | 38.5 | |
Pharmaceuticals: Major | 24.9 | |
Biotechnology | 17.0 | |
Real Estate Investment Trusts | 7.7 | |
Pharmaceuticals: Other | 6.1 | |
Medical/Nursing Services | 3.6 | |
Hospital/Nursing Management | 1.3 | |
Telecommunications Equipment | 0.4 | |
Electrical Products | 0.4 | |
Other | 0.1 |
Country | Weight (%) | |
---|---|---|
United States | 53.1 | |
Switzerland | 11.2 | |
Japan | 7.0 | |
Denmark | 6.2 | |
Britain | 5.1 | |
China | 3.9 | |
Ireland | 2.9 | |
South Korea | 2.7 | |
Belgium | 2.7 | |
Germany | 1.4 | |
Australia | 1.3 | |
Other | 2.5 |
All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.
AGNG traded under the ticker LNGR from inception until April 1, 2021.